GB2333454B - Substituted aromatic compounds for treatment of antibiotic resistant infections - Google Patents

Substituted aromatic compounds for treatment of antibiotic resistant infections

Info

Publication number
GB2333454B
GB2333454B GB9909183A GB9909183A GB2333454B GB 2333454 B GB2333454 B GB 2333454B GB 9909183 A GB9909183 A GB 9909183A GB 9909183 A GB9909183 A GB 9909183A GB 2333454 B GB2333454 B GB 2333454B
Authority
GB
United Kingdom
Prior art keywords
treatment
aromatic compounds
substituted aromatic
antibiotic resistant
resistant infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9909183A
Other languages
English (en)
Other versions
GB9909183D0 (en
GB2333454A (en
Inventor
William Y Ellis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Army
Original Assignee
US Department of Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Army filed Critical US Department of Army
Publication of GB9909183D0 publication Critical patent/GB9909183D0/en
Publication of GB2333454A publication Critical patent/GB2333454A/en
Application granted granted Critical
Publication of GB2333454B publication Critical patent/GB2333454B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24—Anthracenes; Hydrogenated anthracenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
GB9909183A 1998-03-26 1999-03-25 Substituted aromatic compounds for treatment of antibiotic resistant infections Expired - Fee Related GB2333454B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7938398P 1998-03-26 1998-03-26
PCT/US1999/006494 WO1999048461A2 (fr) 1998-03-26 1999-03-25 Composes aromatiques substitues pour le traitement d'infections resistant aux antibiotiques

Publications (3)

Publication Number Publication Date
GB9909183D0 GB9909183D0 (en) 1999-06-16
GB2333454A GB2333454A (en) 1999-07-28
GB2333454B true GB2333454B (en) 2000-08-09

Family

ID=22150207

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9909183A Expired - Fee Related GB2333454B (en) 1998-03-26 1999-03-25 Substituted aromatic compounds for treatment of antibiotic resistant infections

Country Status (6)

Country Link
EP (1) EP1066035A4 (fr)
JP (1) JP2002507557A (fr)
AU (1) AU3012699A (fr)
CA (1) CA2325689A1 (fr)
GB (1) GB2333454B (fr)
WO (1) WO1999048461A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100506870C (zh) 2001-03-08 2009-07-01 宾夕法尼亚州大学理事会 作为抗感染药的表面两亲聚合物
WO2004082634A2 (fr) 2003-03-17 2004-09-30 The Trustees Of The University Of Pennsylvania Polymeres et oligomeres a surface amphiphile et leurs utilisations
DE10316081A1 (de) * 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
DE102010055322A1 (de) * 2010-12-21 2012-06-21 Christian-Albrechts-Universität Zu Kiel Antibakteriell und antimykotisch wirkende Substanzen
AU2018240172C1 (en) 2017-03-20 2019-10-24 Novo Nordisk Health Care Ag Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
CN113226356A (zh) 2018-09-19 2021-08-06 福马治疗股份有限公司 活化丙酮酸激酶r
US10675274B2 (en) 2018-09-19 2020-06-09 Forma Therapeutics, Inc. Activating pyruvate kinase R

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327022A (en) * 1973-08-16 1982-04-27 Sterling Drug Inc. Heterocyclic alkyl naphthols
IL60530A (en) * 1979-08-16 1984-10-31 American Cyanamid Co Animal feed compositions useful as growth promotors and for reduction of fat in animals,comprising phenylethanolamine derivatives and certain such novel compounds
GB9107843D0 (en) * 1991-04-12 1991-05-29 Patterson Laurence H Anti-cancer compounds
WO1997007792A1 (fr) * 1995-08-25 1997-03-06 Department Of The Army, Us Government Compositions de desbutylhalofantrine et leur utilisation

Non-Patent Citations (13)

* Cited by examiner, † Cited by third party
Title
Chem Abs No 76:21121 & E.A.Nodiff et al, J.Med.Chem, 1971, 14(10), 921-925 *
Chem Abs No 77:147532 & W.T.Colwell et al, J.Med.Chem, 1972,15(7), 771-775 *
Chem Abs No 77:96751 & E.A.Nodiff et al, J.Med.Chem, 1972, 15(7), 775-780 *
Chem Abs No 79:142773 & P.N.Craig et al, J.Med.Chem, 1973, 16(6), 661-667 *
Chem Abs No 80:10268 & P.L.Chien et al, J.Med.Chem, 1973 16(10), 1093-1096 *
Chem Abs No 81:163214 & L.C.Washburn et al, J.Med.Chem., 1974, 17(7), 676-682 *
Chem Abs No 83:188214 & E.A. Nodiff et al, J.Med.Chem., 1975, 18(10), 1011-1019 *
Chem abs No 84:12318 & J.S. Gillespie et al, J.Med.Chem, 1975, 18(12), 1223-1227 *
Chem Abs No 90:132704 & L.H.Schmidt et al, Antimicrom.AgentsChemother, 1978, 14(3), 292-314 *
Chem Abs No 90:161936 & K.H.Kim et al, Antimicrob.Agents.Chemother, 1979, 22(4), 366-391 *
Chem Abs No 90:48247 & D.A.Shamblee et al, J.Med.Chem., 197922(1), 86-89 *
Chem Abs No 95:90810 & P.Berntsson., Acta.Pharm.Suec., 1981,18(3), 149-178 *
Chem Abst No 104:101941 & R.Franke et al, Quant.Struct-Ac Chem.Biol., 1985, 4(2), 51-63 *

Also Published As

Publication number Publication date
WO1999048461A3 (fr) 1999-12-16
EP1066035A4 (fr) 2001-05-09
WO1999048461A2 (fr) 1999-09-30
GB9909183D0 (en) 1999-06-16
JP2002507557A (ja) 2002-03-12
AU3012699A (en) 1999-10-18
EP1066035A2 (fr) 2001-01-10
GB2333454A (en) 1999-07-28
CA2325689A1 (fr) 1999-09-30

Similar Documents

Publication Publication Date Title
PT2796138T (pt) Composições antibióticas para tratamento da conjuntivite
EP1194144A4 (fr) Composes antibacteriens
IL146514A0 (en) Antibacterial compounds
PL331470A1 (en) Azabicyclocarbamoyloxylic derivatives of mutiline for antibacterial applications
AU2247701A (en) Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment
GB2333454B (en) Substituted aromatic compounds for treatment of antibiotic resistant infections
HUP9901778A3 (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
AU1212501A (en) Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment
PL348721A1 (en) Use of phosphonoformic acid derivatives for treating infections
AU1646701A (en) Composition for treating respiratory tract infections
AU1212201A (en) Gram-positive selective antibacterial compounds, compositions containing such compounds and methods of treatment
EP1084105A4 (fr) Composes antibacteriens de carbapenem, compositions renfermant ces composes, et methodes de traitement
GB2301353B (en) Treatment of undesirable halogenated organic compounds
EP1021445A4 (fr) Compositions antibacteriennes de carbapenem, preparations les contenant et methodes de traitement
IL142775A0 (en) Use of phosphonoformic acid derivatives for treating infections
AU4706799A (en) Treatment of (staphylococcus) infections
EP1032384A4 (fr) Composes antibacteriens, compositions et procedes de traitement aux carbapenemes
EP1027352A4 (fr) Composes antibacteriens de la classe des carbapenemes, compositions et procedes de traitement
AU1673200A (en) Medicaments for the treatment of lung infections
EP1089729A4 (fr) Composes antibacteriens a base de carbapenem, compositions renfermant ces composes et methodes therapeutiques
EP1089730A4 (fr) Composes antibacteriens a base de carbapenem, compositions renfermant ces composes et methodes therapeutiques
EP0977567A4 (fr) Composes antibacteriens de carbapenem, compositions contenant lesdits composes et methodes de traitement
EP1027353A4 (fr) Composes antibacteriens de carbapenem, compositions contenant ces composes et procedes de traitement
AU6112299A (en) Treatment of effluents
GB9806431D0 (en) Carbapenem antibacterial compounds,compositions containing such compounds and methods of treatment

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20030325